Effectiveness of 'Functional Range Conditioning' in Treating Patients With Chronic Non-specific Low Back Pain
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03456050 |
|
Recruitment Status :
Completed
First Posted : March 7, 2018
Last Update Posted : February 27, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Chronic Low Back Pain | Behavioral: FRC exercise Behavioral: Conventional Exercise | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 56 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Care Provider) |
| Masking Description: | Outcome provider masked about the outcomes |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness of a New Therapeutic Technique 'Functional Range Conditioning' in Treating Patients With Chronic Non-specific Low Back Pain |
| Actual Study Start Date : | March 15, 2018 |
| Actual Primary Completion Date : | December 1, 2018 |
| Actual Study Completion Date : | January 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: FRC group
This group will receive FRC exercise.
|
Behavioral: FRC exercise
The program will consist of hip joint controlled articular rotations (CARs) in standing position for 3 - 5 repetitions. Then, the participant will sit on the floor in what is called 90/90 position which is sitting in hip and flexion in 90 degrees for both the lead (front) and trail (side) leg. The participant will perform a Progressive and regressive angular isometric loadings (PAILs and RAILs) for the trail leg to increase the range of internal rotation, the contraction will be performed three times and the holding of the position will be for two minutes. After expanding the range, the participant will perform Progressive and regressive angular loadings (PALs and RALs) isometric contractions in form of a passive range hold for internal rotation and abduction, for 3 - 5 times. |
|
Experimental: Conventional treatment
This group will receive conventional exercise.
|
Behavioral: Conventional Exercise
The conventional training program in this study will be the routine training for increasing the hip rotation. By screening the scientific literature, the conventional training found to consists of static stretching and strengthening using body weight and/or a band and the time of holding a stretch is about 30 seconds. For that the flexibility exercise will consist of progressive stretching from a prone position (leg fall in a stretch), the participant will perform 3 - 5 repetitions with 30 seconds hold or as tolerated. The strengthening exercise consists of hip abduction (hip opening) using a band or ankle weight from side lying for 10 - 12 repetitions 3 times. |
- Passive range of motion (Hip internal rotation) [ Time Frame: Change from baseline passive hip internal range of motion at 8 weeks ]It will be measured using digital inclinometer
- Strength of the hip abductors (gluteus medius) [ Time Frame: Change from baseline hip abductors strength at 8 weeks ]Strength of the hip abductors will be measured using hand held dynamometer or isokinetic dynamometry,
- Pain Intensitiy [ Time Frame: Change from baseline pain intensity at 8 weeks ]Pain intensity will be assessed using visual analog scale (VAS) (0 - 10 cm with 0 indicates no pain and 10 indicates the worst pain).
- Functional disability [ Time Frame: Change from baseline functional disability at 8 weeks ]Functional disability will be assessed using Oswestry disability index. Each item in the questionnaire is scored on a 0-5 scale with zero indicating the least amount of disability and the 5 indicating most severe disability.The scores for total items answered are summed, and multiplied by two to get the index (range 0 to 100). Zero indicates no disability and 100 indicates maximum possible disability.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 25 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Saudi men and women aged between 25 - 45 years with a diagnosis of chronic non-specific low back pain
Exclusion Criteria:
- Hip, spine and knee pathology.
- Hip and knee replacement.
- Surgery and fracture within the last 6 months.
- Cancer.
- Pregnant women.
- Any medical condition that precluded safe participation in exercise programs such as significant cardiac, pulmonary, neurological disease or mental disorder.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03456050
| Saudi Arabia | |
| King Saud University | |
| Riyad, Saudi Arabia | |
| Study Director: | ahmed alghadir, PHD | King Saud University |
| Responsible Party: | Reem S. Alattallah, Post Graduate student, Principal Investigator, King Saud University |
| ClinicalTrials.gov Identifier: | NCT03456050 |
| Other Study ID Numbers: |
CAMS 028-3839 |
| First Posted: | March 7, 2018 Key Record Dates |
| Last Update Posted: | February 27, 2019 |
| Last Verified: | February 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | Data will be kept secure with principal investigator (Ms. Reem S. Alattallah) and sub-investigator (Dr. Ahmad Alghadir) due to confidentiality issues |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Back Pain Low Back Pain Pain Neurologic Manifestations |

